Wednesday, November 6, 2024
HomeNews

News

Sonivie Receives Ide Approval From FDA for Its Pilot Study to Treat Hypertension

SoniVie, an Israeli company developing a novel proprietary Therapeutic Intra-Vascular Ultrasound System (TIVUS™) to treat a variety of hypertensive disorders, announced that on May...

Brand Institute Partners on Brand Name Development for European Commission Approved Treatment

Brand Institute is proud to announce having worked with Myovant Sciences in developing the brand name ORGOVYX, for an oral medication used to treat...

Fluent Biosciences and Nanocellect Announce Joint Collaboration

Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every researcher, and NanoCellect Biomedical, Inc., a leader in the...

FDA Authorizes Moderna and Pfizer-BioNTech COVID-19 Vaccines for Children Down to 6 Months of Age

The U.S. Food and Drug Administration authorized emergency use of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19...

Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Lyra Therapeutics, Inc., a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise, sustained and local delivery of medications to the ear,...
0FansLike
0FollowersFollow
spot_img

Hot Topics